SNOA
Sonoma Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.11
−2.63%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 15.86x
- P/E 2028E
- —
- P/S forward
- 0.47x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.81x
- Price / sales
- 0.24x
- Price / cash flow
- -2.62x
Enterprise value
- Enterprise value
- $716.2K
- EV / sales
- 0.03x
- EV / EBITDA
- -0.46x
- EV / EBIT
- -0.51x
- Market cap
- $5.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026